The American College of Chest Physicians has released its first comprehensive clinical guideline specifically addressing obstructive sleep apnea in pregnant patients. The guideline, published in August 2026, provides nine evidence-based recommendations to help healthcare providers screen, diagnose, treat, and monitor sleep-disordered breathing during pregnancy. For expectant mothers and those planning pregnancy, this development carries important implications for maternal and fetal health.

Why This Guideline Matters

Sleep-disordered breathing during pregnancy is more common than many realize, and the consequences can be serious. Research has linked untreated sleep apnea in pregnant patients to preterm birth, reduced fetal growth, higher rates of neonatal intensive care unit admission, longer hospital stays, and even congenital anomalies. Despite these risks, the condition has historically received minimal clinical attention during pregnancy, with symptoms often dismissed as typical pregnancy discomforts.

Dr. Carolyn D’Ambrosio, the lead author of the guideline, emphasized that the guidance aims to elevate awareness among both patients and their healthcare teams. She noted that symptoms occurring during pregnancy should not be automatically assumed to resolve after delivery, and that disordered breathing can have serious consequences for both parent and baby.

Key Screening and Diagnostic Recommendations

The guideline recommends that all pregnant individuals be screened for sleep-disordered breathing. Screening can use either pregnancy-specific tools or standard screening questionnaires. When evaluation is warranted, providers may use either at-home diagnostic devices or laboratory-based sleep studies to confirm a diagnosis, giving patients some flexibility based on their circumstances and preferences.

For patients already using continuous positive airway pressure (CPAP) therapy before pregnancy, the guideline suggests switching to automatic positive airway pressure (APAP) devices during pregnancy, as these may better accommodate the physiological changes of pregnancy.

Treatment Thresholds and Options

The guideline establishes specific treatment thresholds based on the apnea-hypopnea index, or AHI, which measures breathing disruptions per hour. For mild to moderate sleep apnea (AHI between 5 and 15), treatment is recommended if the patient experiences symptoms or has additional risk factors or comorbidities. For more severe sleep apnea (AHI greater than 15), PAP therapy is recommended regardless of symptoms or other factors.

When treatment is indicated, positive airway pressure therapy in any form is preferred over no treatment at all. The guideline also prioritizes PAP therapy over alternative treatments. For patients who remain sleepy despite treatment, scheduled daytime naps are suggested as the first approach, with stimulant medications considered only if napping does not provide sufficient relief.

What Buyers and Patients Should Consider

For expectant mothers, this guideline should prompt a conversation with their healthcare provider if they experience symptoms such as loud snoring, observed breathing pauses, excessive daytime sleepiness, or morning headaches. Early screening can prevent serious complications and ensure both mother and baby receive optimal care throughout pregnancy and delivery.

If you have been diagnosed with sleep apnea before pregnancy, do not assume your condition will disappear after delivery. The guideline recommends reassessment for sleep-disordered breathing in the postpartum period, as some patients may continue to require treatment or may develop new symptoms after birth.

Patients who use PAP devices should ensure they have equipment suited to their current health status. Major sleep apnea retailers now offer specialized guidance and product options for pregnant users, making it easier to find devices and accessories tailored to pregnancy needs.

Important Limitations to Understand

It is important to note that all nine recommendations in the guideline carry a conditional status with very low certainty of evidence. This reflects the reality that research specifically examining sleep apnea in pregnancy remains limited. The recommendations are based on the best available evidence and expert consensus, but researchers continue to study this population to strengthen the evidence base over time.

Moving Forward

This guideline represents a significant step in bringing sleep-disordered breathing into the conversation around prenatal care. Expectant mothers who suspect they may have sleep apnea, as well as those with a known diagnosis, should share this information with their prenatal care team. Early identification and appropriate management can reduce risks and support healthier outcomes for both parent and child.